PE-Backed MedPharm Merges With CDMO Tergus Pharma
MedPharm, an Ampersand Capital Partners portfolio company, announced on July 8 a merger with Tergus Pharma, backed by Great Point Partners. The combined organization will operate under the MedPharm name, establishing a leading, end-to-end contract development and manufacturing organization (CDMO) with robust scientific, clinical trial manufacturing and commercial production capabilities. Tergus Pharma is a CDMO that provides formulation development, in vitro permeating testing, in vitro release testing, skin biology, analytical services and clinical manufacturing services for branded and generic dermatology products. MedPharm is an end-to-end contract service provider of topical and... Read More »
DuPont to Acquire Donatelle Plastics
DuPont announced it has signed an agreement to acquire New Brighton, Minnesota-based Donatelle Plastics. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. Donatelle Plastics is a medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. Founded in 1967, Donatelle Plastics has a workforce of more than 400 employees and operates a facility strategically located in a medical technologies hub near leading original equipment manufacturers. DuPont is an American multinational company that produces various products... Read More »
Siegfried Acquires Curia Global’s Early-Phase Manufacturing Site
Siegfried announced on June 13 that it was expanding its global contract development management organization (CDMO) abilities with the acquisition of an early-phase manufacturing site in Grafton, Wisconsin from Curia Global. The Wisconsin facility specializes in early-phase development and manufacturing services and employs more than 80 workers. Siegfried develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. It is based in Zofingen, Switzerland. Curia Global is a... Read More »
PE Firm Great Point Partners Acquires Germany-Based CDMO
Great Point Partners (GPP) announced on June 13 the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization (CDMO) based in Ilsenburg, Germany. Founded in 2007, Lyocontract operates from a state-of-the-art pharmaceutical manufacturing facility providing aseptic liquid filling, lyophilization and packaging services. Compliant with the European Union’s Annex 1 standards, the CDMO specializes in the production of liquid and freeze-dried parenteral drugs, distributing globally for both clinical and commercial use. Founded in 2003 and based in Greenwich, Connecticut, GPP is a healthcare investment firm that has provided growth... Read More »
Formosa Laboratories Expands North American CRO/CDMO Footprint
Formosa Laboratories, Inc. announced that it has successfully completed its acquisition of SynChem, Inc., headquartered in the Chicago MSA suburb of Elk Grove Village. Founded in 1997, SynChem is a chemistry-based contract research organization (CRO) specializing in organic synthesis, process development and medicinal chemistry. Since its inception, SynChem has completed more than 4,500 projects for wide range of customers, including multi-national pharmaceutical companies, biotech companies, drug discovery companies and chemical and agrochemical companies. Founded in 1995, Formosa Laboratoriesap is a leading active pharmaceutical ingredients (API) supplier and contract development and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
